Issue 5, 2012

Osmium(vi) nitrido complexes bearing azole heterocycles: a new class of antitumor agents

Abstract

Eight new nitridoosmium(VI) complexes with the general formula [OsVI(N)Cl3(Hazole)2] have been synthesized and characterized. The cellular uptake and the antiproliferative activities of these compounds against a panel of human cancer cell lines have been investigated. Complexes with pyrazole derivatives (1, 2, 3 and 4) are found to possess significant in vitro cytotoxicity. Further studies of compounds 1 and 3 indicate that they induce S phase arrest in HeLa cells followed by apoptosis, possibly as a result of binding with DNA.

Graphical abstract: Osmium(vi) nitrido complexes bearing azole heterocycles: a new class of antitumor agents

Supplementary files

Article information

Article type
Edge Article
Submitted
08 Dec 2011
Accepted
02 Feb 2012
First published
03 Feb 2012

Chem. Sci., 2012,3, 1582-1588

Osmium(VI) nitrido complexes bearing azole heterocycles: a new class of antitumor agents

W. Ni, W. Man, S. Yiu, M. Ho, M. T. Cheung, C. Ko, C. Che, Y. Lam and T. Lau, Chem. Sci., 2012, 3, 1582 DOI: 10.1039/C2SC01031C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements